Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.
Strong outlook in uncertain times
Benchmark’s recent Q1 FY22 results highlighted strong operating trends in its three business areas...
Read more
Strong performance and improving outlook
Benchmark Holdings’ FY21 and particularly its Q4 (July to September) results confirmed the strong...
Read more
Benchmark Holdings - Strong Q3 for Nutrition and Genetics
Benchmark Holdings’ recent Q3 (March-June) results show strong revenue and profit growth in its...
Read more
Cleared to launch BMK08 / Ectosan Vet in Norway
Norway’s Medicines Agency (NoMA) has approved Benchmark Holdings’ parasiticide BMK08 (imidacloprid)...
Read moreGrowth drivers aligned with aquaculture sustainability goals
BMK reported solid H1 2021 progress in line with expectations. 11% (Constant Exchange Rates)...
Read more
Well set ahead of key product launches
BMK is seeing the rewards from its focus on aquaculture and a tighter cost base; continuing...
Read more
Progress on the road to profitability
BMK transformed operations during FY20 against the challenging macro conditions brought about by...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
